BG IRIS Research Client Login
Transactions
Services
Overview
Solutions
Sector expertise
Research
Insights
Overview
White Papers
Blog
Reports
Client Focus
About us
Overview
Senior Team
News
Events
Careers
Overview
Early careers
Experienced hires
Employee Growth Stories
Media
Press
Videos
Contact
Search
BG IRIS Research Client Login
Archives Portfolio
Bryan, Garnier & Co acts as Joint Bookrunner to GenSight on its EUR 25 million Follow-on Offering
Bryan, Garnier & Co acts as Joint Bookrunner to Targovax on its NOK 75 million Follow-on Offering
Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to McPhy on a EUR 180m Follow-on Offering including Strategic Investments from Chart Industries and Technip Energies
Bryan, Garnier & Co acts as Sole Financial Advisor to INNOTHERA Group on its acquisition of Gibaud
Bryan, Garnier & Co acts as Sole Financial Advisor to Sword Group SE on the disposal of its French unit, Sword France, to Argos Wityu
Bryan, Garnier & Co acts as Sole Financial Advisor to EasyVista (Euronext: ALEZV) on a contemplated take-private led by Eurazeo PME
Bryan, Garnier & Co acts as Joint Bookrunner on Sensorion’s EUR 31 million Follow-on Offering with top tier US and European biotech specialists and institutional investors
Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 78 million Follow-on Offering
Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 270 million Follow-on Offering
Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Innovasjon on the sale of the company to Visolit
1
…
20
21
22
23
24
…
60
Privacy Preference Center
Privacy Preferences